Active Financial Statements From 2010 to 2024
| ACTI Stock | SEK 0.26 0.01 4.00% |
Check Active Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Active Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Active financial statements analysis is a perfect complement when working with Active Biotech Valuation or Volatility modules.
Active |
Active Biotech AB Company Shares Owned By Insiders Analysis
Active Biotech's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Active Biotech Shares Owned By Insiders | 45.94 % |
Most of Active Biotech's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Active Biotech AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 45.94% of Active Biotech AB are shares owned by insiders. This is 202.64% higher than that of the Biotechnology sector and 223.98% higher than that of the Health Care industry. The shares owned by insiders for all Sweden stocks is notably lower than that of the firm.
Active Biotech AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Active Biotech's current stock value. Our valuation model uses many indicators to compare Active Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Active Biotech competition to find correlations between indicators driving Active Biotech's intrinsic value. More Info.Active Biotech AB is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Active Biotech's earnings, one of the primary drivers of an investment's value.About Active Biotech Financial Statements
Active Biotech shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Active Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in Active Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on Active Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Active Biotech AB , a biotechnology company, develops drugs for the treatment of neurodegenerative diseases, autoimmunityinflammatory, and cancer. Active Biotech AB was incorporated in 1982 and is based in Lund, Sweden. Active Biotech operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.